HPVゲノム編集破壊能と腫瘍溶解性の相乗効果を狙ったがん治療アデノベクターの開発

• Project/Area Number: 25K02541
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 50020:Tumor diagnostics and therapeutics-related
• Research Institution: National Cancer Center Japan
• Principal Investigator: 清野 透 国立研究開発法人国立がん研究センター, 先端医療開発センター, プロジェクトリーダー (10186356)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000); Fiscal Year 2027: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000); Fiscal Year 2026: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000); Fiscal Year 2025: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)